SMTL ID : 5nzp.1

Crystal structure of human 3-phosphoglycerate dehydrogenase in complex with 3-Hydroxybenzisoxazole

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.30 Å

Oligo State

homo-dimer

Ligands

2 x 9EW: 1,2-benzoxazol-3-ol(Non-covalent)

9EW.1: 6 residues within 4Å: Chain A: Y.79, P.81, T.112, S.117, T.118, L.121 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:Y.79, A:Y.79, A:P.81, A:T.112, A:T.118, A:L.121 Hydrogen bonds: A:S.117 9EW.2: 8 residues within 4Å: Chain B: G.57, Y.79, P.81, T.112, L.115, S.117, T.118, L.121 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:Y.79, B:Y.79, B:P.81, B:T.112, B:T.118, B:L.121, B:L.121 Hydrogen bonds: B:S.117

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Unterlass, J.E. et al., Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer. Oncotarget (2018)

Release Date

2017-06-14

Peptides

D-3-phosphoglycerate dehydrogenase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
A

D-3-phosphoglycerate dehydrogenase